Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis
NCT ID: NCT02468479
Last Updated: 2017-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2015-06-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Treatments for Cirrhosis With Varicose Veins
NCT06961474
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment
NCT03443934
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis
NCT03438916
A New Screening Strategy for Varices
NCT02024347
Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver Cirrhosis
NCT03513887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No relevant intervention.
No relevant intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Consecutive admission.
3. Permitted to physical examinations.
4. Informed consents.
Exclusion Criteria
2. Malignancy.
3. Uncontrolled infection.
4. Severe chronic diseases.
5. Poor patient compliance.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Hospital of Shenyang Military Region
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xingshun Qi
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaozhong Guo, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Gastroenterology, General Hospital of Shenyang Military Area
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, General Hospital of Shenyang Military Area
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Li H, Wang R, Mendez-Sanchez N, Peng Y, Guo X, Qi X. Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis. Arch Med Sci. 2019 Mar;15(2):434-448. doi: 10.5114/aoms.2018.74788. Epub 2018 Mar 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAWV-LC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.